Gonzalo Colmenarejo

Dr. Gonzalo Colmenarejo

Cheminformatics & AI Group, IMDEA Food, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2003 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
GCGonzalo Colmenarejo
Gonzalo Colmenarejo

5 March 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IPImanol Peña
Imanol Peña
MMM. Pilar Manzano
M. Pilar Manzano
JCJuan Cantizani
Juan Cantizani
AKAlbane Kessler
Albane Kessler
JPJulio Alonso Padilla
Julio Alonso Padilla
JMJ. Julio Martin
J. Julio Martin
Using whole-cell phenotypic assays, the GlaxoSmithKline high-throughput screening (HTS) diversity set of 1.8 million compounds was screened against the three kinetoplastids most relevant to human disease, i.e. Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Secondary confirmatory and orthogonal intracellular anti-parasiticidal assays were conducted and the potential for non-specific cytotoxicity determined. Hit compounds were chemically clustered and triaged for desirable physicochemical properties. The hypothetical biological target space covered by these diversity sets was investigated through bioinformatics methodologies. Consequently, three anti-kinetoplastid chemical boxes of ~200 compounds each were assembled. Functional analyses of these compounds suggest a wide array of potential modes of action against kinetoplastid kinases, proteases and cytochromes as well as potential host–pathogen targets. This is the first published parallel high throughput screening of a pharma compound collection against kinetoplastids. The compound sets are provided as an open resource for future lead discovery programs and to address important research questions.

27 October 2001 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
GCGonzalo Colmenarejo
Gonzalo Colmenarejo
AAAna Alvarez-Pedraglio
Ana Alvarez-Pedraglio
Jose-Luis LavanderaJose-Luis Lavandera
Jose-Luis Lavandera
Models to predict binding affinities to human serum albumin (HSA) should be very useful in the pharmaceutical industry to speed up the design of new compounds, especially as far as pharmacokinetics is concerned. We have experimentally determined through high-performace affinity chromatography the binding affinities to HSA of 95 diverse drugs and druglike compounds. These data have allowed us the derivation of quantitative structure−activity relationship models to predict binding affinities to HSA of new compounds on the basis of their structure. Simple linear, one-variable models have been derived for specific families of compounds (r2 ≥ 0.80; q2 ≥ 0.62): β-adrenergic antagonists, steroids, COX inhibitors, and tricyclic antidepressants. Also, global models have been derived to be applicable to the whole medicinal chemical space by using the full database of HSA binding constants described above. For this aim, a genetic algorithm has been used to exhaustively search and select for multivariate and nonlinear equations, starting from a large pool of molecular descriptors. The resulting models display good fits to the experimental data (r2 ≥ 0.78; LOF ≤ 0.12). In addition, both internal (cross validation and randomization) and external validation tests have demonstrated that these models have good predictive power (q2 ≥ 0.73; PRESS/SSY ≤ 0.23; r2 ≥ 0.82 for the external set). Statistical analysis of the equation populations indicates that hydrophobicity (as measured by the ClogP) is the most important variable determining the binding extent to HSA. In addition, structural factors (especially the topological 6χring index and some Jurs descriptors) also frequently appear as descriptors in the best equations. Therefore, binding to HSA turns out to be determined by a combination of hydrophobic forces together with some modulating shape factors. This agrees with X-ray structures of HSA alone or bound to ligands, where the binding pockets of both sites I and II are composed mainly of hydrophobic residues.

1 March 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
NDNoton Dutta
Noton Dutta
LKLee G. Klinkenberg
Lee G. Klinkenberg
MVMaria-Jesus Vazquez
Maria-Jesus Vazquez
DSDelfina Segura-Carro
Delfina Segura-Carro
GCGonzalo Colmenarejo
Gonzalo Colmenarejo
PKPetros C. Karakousis
Petros C. Karakousis
The stringent response enzyme is a promising new target for Mycobacterium tuberculosis persisters.

16 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
GCGonzalo Colmenarejo
Gonzalo Colmenarejo
The prevalence of childhood and adolescence overweight an obesity is raising at an alarming rate in many countries. This poses a serious threat to the current and near-future health systems, given the association of these conditions with different comorbidities (cardiovascular diseases, type II diabetes, and metabolic syndrome) and even death. In order to design appropriate strategies for its prevention, as well as understand its origins, the development of predictive models for childhood/adolescent overweight/obesity and related outcomes is of extreme value. Obesity has a complex etiology, and in the case of childhood and adolescence obesity, this etiology includes also specific factors like (pre)-gestational ones; weaning; and the huge anthropometric, metabolic, and hormonal changes that during this period the body suffers. In this way, Machine Learning models are becoming extremely useful tools in this area, given their excellent predictive power; ability to model complex, nonlinear relationships between variables; and capacity to deal with high-dimensional data typical in this area. This is especially important given the recent appearance of large repositories of Electronic Health Records (EHR) that allow the development of models using datasets with many instances and predictor variables, from which Deep Learning variants can generate extremely accurate predictions. In the current work, the area of Machine Learning models to predict childhood and adolescent obesity and related outcomes is comprehensively and critically reviewed, including the latest ones using Deep Learning with EHR. These models are compared with the traditional statistical ones that used mainly logistic regression. The main features and applications appearing from these models are described, and the future opportunities are discussed.

30 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
MAMahmood M. Alam
Mahmood M. Alam
ASAna Sanchez-Azqueta
Ana Sanchez-Azqueta
OJOmar Janha
Omar Janha
EFErika L. Flannery
Erika L. Flannery
AMAmit Mahindra
Amit Mahindra
ATAndrew B. Tobin
Andrew B. Tobin
Targeting parasite's protein kinase: Malaria elimination goals are constantly eroded by the challenge of emerging drug and insecticide resistance. Alam et al. have taken established drug targets—CLK protein kinases involved in regulation of RNA splicing—and investigated how inhibition of the parasite's enzymes blocks completion of its complex life cycle. They identified an inhibitor of the parasite's CLK protein kinase that was 100-fold less active against the most closely related human protein kinase and effective at clearing rodent malaria parasites. Not only does this compound halt the development of sexual stages but it also limits transmission to the mosquito vector of the parasite, a key requirement for malaria drugs. Science , this issue p. eaau1682